Caribou Biosciences, Inc.
CRBU
$1.84
$0.000.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -39.18% | 79.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -39.18% | 79.30% | |||
| Cost of Revenue | -13.45% | 6.31% | |||
| Gross Profit | 8.35% | 1.63% | |||
| SG&A Expenses | -5.98% | -6.72% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.47% | 2.52% | |||
| Operating Income | 7.64% | 3.22% | |||
| Income Before Tax | 7.22% | 1.85% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.30% | 3.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.30% | 3.85% | |||
| EBIT | 7.64% | 3.22% | |||
| EBITDA | 7.71% | 3.47% | |||
| EPS Basic | 6.60% | 5.11% | |||
| Normalized Basic EPS | 8.56% | 3.14% | |||
| EPS Diluted | 6.60% | 5.11% | |||
| Normalized Diluted EPS | 8.56% | 3.14% | |||
| Average Basic Shares Outstanding | 1.40% | 1.33% | |||
| Average Diluted Shares Outstanding | 1.40% | 1.33% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||